Nucleocytoplasmic Transport Defects in Neurodegenerative Diseases

Path: mechanisms/nucleocytoplasmic-transport-defects Title: Nucleocytoplasmic Transport Defects in Neurodegenerative Diseases Tags: section:mechanisms, kind:pathology, topic:nucleocytoplasmic-transport, topic:als, topic:ftd, topic:alzheimers

Introduction

flowchart TD
    Nucleocytoplasmic_Transport_De["Nucleocytoplasmic Transport Defects in Neurodege"]
    Nucleocytoplasmic_Transport_De["Neurodegenerative"]
    Nucleocytoplasmic_Transport_De -->|"related to"| Nucleocytoplasmic_Transport_De
    style Nucleocytoplasmic_Transport_De fill:#81c784,stroke:#333,color:#000
    Nucleocytoplasmic_Transport_De["Path"]
    Nucleocytoplasmic_Transport_De -->|"related to"| Nucleocytoplasmic_Transport_De
    style Nucleocytoplasmic_Transport_De fill:#81c784,stroke:#333,color:#000
    Nucleocytoplasmic_Transport_De["nucleocytoplasmic-transport-defects"]
    Nucleocytoplasmic_Transport_De -->|"related to"| Nucleocytoplasmic_Transport_De
    style Nucleocytoplasmic_Transport_De fill:#81c784,stroke:#333,color:#000
    style Nucleocytoplasmic_Transport_De fill:#4fc3f7,stroke:#333,color:#000

Nucleocytoplasmic transport (NCT) — the regulated movement of proteins and RNA between the nucleus and cytoplasm through nuclear pore complexes (NPCs) — has emerged as a central pathological mechanism in multiple neurodegenerative diseases^{1Nat Neurosci (2016)2016 · PMID 26605882Open reference}. The nucleus and cytoplasm maintain distinct compositions essential for cellular function: transcription factors, histones, and splicing machinery must be imported into the nucleus, while mRNAs, tRNAs, and ribosomal subunits must be exported to the cytoplasm. This bidirectional trafficking depends on the integrity of NPCs, the Ran GTPase gradient, and nuclear transport receptors (importins and exportins). Disruption of NCT has been documented in amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD), Alzheimer’s disease, and Parkinson’s disease.

Understanding NCT defects provides critical insights into disease mechanisms and therapeutic opportunities. The nuclear envelope represents a vulnerable boundary where multiple disease processes converge.

Nuclear Pore Complex Architecture

Structure and Function

The nuclear pore complex is a massive protein assembly (~125 MDa in humans) composed of multiple copies of ~30 different nucleoporins (Nups)^{2J Cell Biol (2000)2000 · PMID 10898711Open reference}. The NPC architecture includes:

Core structural components:

• Nuclear ring: Anchors scaffold on the nuclear side

• Cytoplasmic ring: Anchors scaffold on the cytoplasmic side

• Central scaffold: Provides structural integrity

• FG-nucleoporins: Form selective barrier

Transport mechanism:

• FG-nucleoporins create a hydrogel-like barrier

• Transport receptors (karyopherins) bind FG repeats

• Receptor-cargo complexes transit through channel

• Size and interaction selectivity determine specificity^{3Petersen & Blobel, Nature (1996)1996 · PMID 8780221Open reference}

Nucleoporin Composition

The NPC contains approximately 500 nucleoporin proteins arranged symmetrically^{4Nature (2002)2002 · PMID 11961557Open reference}:

Scaffold nucleoporins:

• NUP107, NUP133: Core scaffold

• NUP160, NUP96: Y-complex

• NUP205, NUP188: Nup107 complex

FG-nucleoporins:

• NUP62, NUP58, NUP54: Central channel

• NUP153: Nuclear basket

• NUP358/RanBP2: Cytoplasmic filaments

Membrane components:

• POM121: Membrane anchoring

• NDC1: Pore membrane protein

• GP210: Perinuclear membrane

Nucleoporins in Neurodegeneration

Mutations in several nucleoporin genes have been linked to neurodegenerative diseases^{5Nat Neurosci (2018)2018 · DOI 10.1038/s41593-018-0229-7Open reference}:

ALS-associated nucleoporins:

• NUP88: Mutations cause ALS

• NUP54: Co-aggregates with TDP-43

• NUP58: Dysregulated in disease

• NUP205: Rare variants in ALS

Altered expression:

• NUP98: Dysregulated in AD

• NUP62: Sequestered in inclusions

• NUP153: Altered nuclear import

Ran GTPase Cycle

Mechanism

The Ran GTPase system maintains the directionality of NCT^{6Görlich & Kutay, Annu Rev Cell Dev Biol (1999)1999 · PMID 10631263Open reference}:

Key components:

• RanGAP: GTPase activating protein (cytoplasm)

• RCC1: Guanine nucleotide exchange factor (nucleus)

• RanGTP: Active form in nucleus

• RanGDP: Inactive form in cytoplasm

Import cycle:

1. Importin-β binds cargo with NLS in cytoplasm

2. Complex enters nucleus via NPC

3. RanGTP binds importin-β, causing cargo release

4. Importin-RanGTP returns to cytoplasm

5. RanGAP hydrolyzes GTP, releasing importin

Export cycle:

1. Exportin binds cargo with NES in nucleus

2. RanGTP binding stabilizes complex

3. Complex exits nucleus

4. RanGAP hydrolyzes GTP in cytoplasm

5. Cargo and exportin released

Dysregulation in Neurodegeneration

Alterations in Ran GTPase cycle components have been observed^{7Exp Cell Res (2010)2010 · PMID 20064540Open reference}:

RanGAP dysfunction:

• Reduced RanGAP activity in AD

• Oxidative modification of RanGAP

• Impaired RanGTP generation

RCC1 alterations:

• Reduced RCC1 expression in disease

• Histone modifications affect RCC1

• Chromatin remodeling disrupted

RanGTP gradient disruption:

• Nuclear RanGTP depletion

• Cytoplasmic Ran accumulation

• Bidirectional transport impairment

Transport Receptors and Cargo

Karyopherin Family

The karyopherin family includes importins and exportins^{8Kim & Ahn, Exp Mol Med (2001)2001 · PMID 11376194Open reference}:

Importins (karyopherin-β family):

• Importin-β: Major import receptor

• Importin-α: Adapter for classical NLS

• Importin-7, Importin-8: Specialized imports

Exportins (karyopherin-β family):

• CRM1/XPO1: Major export receptor

• Exportin-t: tRNA export

• Exportin-5: miRNA export

Nuclear Localization Signals

Cargo proteins contain specific signals for nuclear import^{9J Biol Chem (2007)2007 · PMID 17209055Open reference}:

Classical NLS (cNLS):

• Monopartite: Single basic cluster (PKKKRKV)

• Bipartite: Two basic clusters separated by 10-30 aa

• Recognized by Importin-α

Non-classical NLS:

• Proline-rich NLS

• Hydrophobic NLS

• Post-translationally modified NLS

Nuclear Export Signals

Proteins containing NES are exported from the nucleus^{10J Cell Biol (1997)1997 · PMID 9308962Open reference}:

Leucine-rich NES:

• Classic hydrophobic motif

• Recognized by CRM1

• Regulated by phosphorylation

Other NES types:

• Proline-rich NES

• Arginine-rich NES

• Cyclophilin A-type NES

Defects in Specific Diseases

Amyotrophic Lateral Sclerosis (ALS)

NCT defects are a hallmark of ALS^{2J Cell Biol (2000)2000 · PMID 10898711Open reference}0:

TDP-43 pathology:

• TDP-43 normally nuclear, mislocalized to cytoplasm in 95% of ALS

• Loss of nuclear TDP-43 disrupts RNA processing

• Cytoplasmic aggregates sequester NCT components

FUS pathology:

• FUS mutations cause familial ALS

• FUS normally shuttles between nucleus and cytoplasm

• Disease mutations disrupt nuclear localization

• Cytoplasmic FUS inclusions

C9orf72 expansion:

• Hexanucleotide repeat expansions cause ~40% of familial ALS

• RNA foci sequester NCT proteins

• Dipeptide repeats impair NCT

• Nuclear envelope damage

Nucleoporin alterations:

• NUP62 aggregation in ALS spinal cord

• NUP54 co-aggregates with TDP-43

• NPC integrity compromised

• Nuclear pore permeability increased

Frontotemporal Dementia (FTD)

Similar NCT defects occur in FTD^{2J Cell Biol (2000)2000 · PMID 10898711Open reference}1:

TDP-43 pathology:

• TDP-43 inclusions in 50% of FTD cases

• Similar to ALS (TDP-43 proteinopathy)

• NCT dysfunction common to both diseases

FUS pathology:

• FUS inclusions in some FTD subtypes

• Nuclear import defects

• Cytoplasmic mislocalization

Tau pathology:

• MAPT mutations cause familial FTD

• Tau affects nuclear pore integrity

• NCT impairment in tauopathies

Alzheimer’s Disease

NCT defects contribute to Alzheimer’s disease pathogenesis^{2J Cell Biol (2000)2000 · PMID 10898711Open reference}2:

Nuclear envelope alterations:

• Nuclear lamina abnormalities

• NPC assembly defects

• Perinuclear chromatin organization disrupted

Transport impairment:

• Importin-α degradation

• Reduced nuclear import

• Transcription factor mislocalization

Tau pathology effects:

• Tau accumulates in nucleus

• Binds nuclear pore components

• Disrupts NCT

Parkinson’s Disease

NCT defects in Parkinson’s disease^{2J Cell Biol (2000)2000 · PMID 10898711Open reference}3:

Alpha-synuclein effects:

• α-Synuclein aggregation in Lewy bodies

• Nuclear membrane involvement

• Possible NCT impairment

Parkin and PINK1:

• Mitochondrial NCT connections

• Nuclear export alterations

• Impaired protein quality control

Molecular Mechanisms

Nuclear Pore Complex Disassembly

NPC disassembly occurs during disease^{2J Cell Biol (2000)2000 · PMID 10898711Open reference}4:

Post-translational modifications:

• Hyperphosphorylation of nucleoporins

• O-GlcNAc modification changes

• SUMOylation alterations

Proteolytic cleavage:

• Caspase cleavage of Nups

• Calpain involvement

• MMP-mediated degradation

Dysregulation triggers:

• Oxidative stress

• ER stress

• Mitochondrial dysfunction

RNA Processing Defects

NCT disruption affects RNA metabolism^{2J Cell Biol (2000)2000 · PMID 10898711Open reference}5:

mRNA export:

• TREX complex recruitment impaired

• Nuclear mRNA accumulation

• Splicing defects magnified

RNA binding proteins:

• TDP-43 cytoplasmic mislocalization

• FUS dysregulation

• hnRNP trafficking disrupted

Translation consequences:

• Nuclear translation arrest

• Cytoplasmic mRNA overload

• Ribosome biogenesis stress

Protein Quality Control

NCT intersects with proteostasis^{2J Cell Biol (2000)2000 · PMID 10898711Open reference}6:

Proteasome localization:

• Nuclear proteasome function

• Ubiquitination pathways

• Protein clearance

Autophagy connections:

• Nuclear envelope turnover

• Aggresome formation

• Selective degradation

Therapeutic Implications

Targeting NCT Components

NCT defects offer therapeutic opportunities^{2J Cell Biol (2000)2000 · PMID 10898711Open reference}7:

Kinase inhibitors:

• CDK5 inhibitors protect NCT

• GSK3β modulation

• Casein kinase inhibition

Transport modulators:

• CRM1 inhibitors (selinexor)

• Importin-targeting compounds

• RanGTP gradient stabilization

Nuclear Pore Repair

NPC integrity restoration strategies^{2J Cell Biol (2000)2000 · PMID 10898711Open reference}8:

Nucleoporin expression:

• Viral vector delivery

• Small molecule stabilizers

• Protein replacement therapy

Chaperone approaches:

• Hsp90 for nucleoporins

• Nuclear import chaperones

• Proteostasis enhancement

Gene Therapy Approaches

Genetic interventions targeting NCT^{2J Cell Biol (2000)2000 · PMID 10898711Open reference}9:

AAV vectors:

• Nup gene delivery

• Transport factor expression

• Modifier gene therapy

Antisense oligonucleotides:

• Reduce toxic protein expression

• Modulate NCT protein levels

• Target-specific mutations

Key Proteins and Genes

Cross-Links to Related Mechanisms

• Stress Granules

• Protein Aggregation

• ALS Mechanisms

• FTD Mechanisms

• Alzheimer’s Disease Mechanisms

• Parkinson’s Disease Mechanisms

• RNA Metabolism Defects

• TDP-43 Pathology

See Also

• Nuclear Pore Complex

• TDP-43 Pathology

• Stress Granules

• RNA Metabolism Defects

• Amyotrophic Lateral Sclerosis

• Frontotemporal Dementia

• Alzheimer’s Disease

• Parkinson’s Disease

External Links

• PubMed

• KEGG Pathways

Additional Mechanisms and Disease Context

DNA Damage Response and NCT

The DNA damage response intersects with nucleocytoplasmic transport:

Repair factor localization:

• 53BP1 requires nuclear import

• ATM activation in cytoplasm

• Rad51 nucleocytoplasmic shuttling

• DNA-PKcs regulation

Transcriptional consequences:

• p53 nuclear import critical

• FOXO transcription factor localization

• NF-κB pathway regulation

• Stress response modulation

Mitochondrial-Nuclear Cross-Talk

Mitochondrial dysfunction affects nuclear transport:

** retrograde signaling:**

• ROS affects nuclear pore integrity

• ATP depletion impairs active transport

• Mitochondrial protein import connections

• Mitochondrial stress response

Nuclear-mitochondrial coordination:

• Mitochondrial DNA transcription

• Nuclear-encoded mitochondrial protein import

• Calcium signaling coordination

• Metabolic regulation

ER-Nuclear Communication

The endoplasmic reticulum interacts with nuclear transport:

ER stress and NCT:

• Unfolded protein response

• ATF6 activation requires import

• XBP1 splicing localization

• ER-associated degradation

Membrane contact sites:

• ER-nuclear envelope junctions

• Lipid transfer mechanisms

• Calcium signaling

• Protein quality control

Experimental Models and Methods

Cell Culture Models

Cell lines used:

• Motor neuron models (NSC-34, MN-1)

• Induced neurons (iNs)

• Patient-derived iPSCs

• HEK293 for transport studies

Experimental approaches:

• Reporter constructs for transport

• Fluorescent nuclear import assays

• Import/export analysis

• Time-lapse imaging

Animal Models

Transgenic models:

• TDP-43 transgenic mice

• FUS mutant mice

• C9orf72 BAC mice

• Nucleoporin mutants

Readouts:

• Motor behavior testing

• Histopathology

• Transport assays

• Nuclear envelope morphology

Biochemical Approaches

Transport assays:

• In vitro nuclear import

• Digitonin-permeabilized cells

• Recombinant protein import

• Radiolabeled cargo

Interaction studies:

• Co-immunoprecipitation

• Proximity ligation assays

• BiFC analysis

• ITC measurements

Biomarkers and Clinical Implications

Fluid Biomarkers

NCT dysfunction can be detected in patient samples:

CSF markers:

• Neurofilament light chain

• Tau species

• NUP fragments

• TDP-43 fragments

Blood markers:

• Peripheral blood mononuclear cells

• Extracellular vesicles

• Cell-free DNA

• Protein aggregates

Imaging Biomarkers

MRI approaches:

• Nuclear envelope morphology

• White matter integrity

• Brain atrophy patterns

• Functional connectivity

PET imaging:

• Glucose metabolism

• Neuroinflammation

• Protein aggregate detection

• Synaptic density

Clinical Trials

NCT-targeted approaches:

• CRM1 inhibitors in trials

• Importin modulators

• Nuclear pore stabilizers

• Gene therapy approaches

Trial design considerations:

• Patient selection

• Biomarker endpoints

• Imaging correlates

• Functional outcomes

Network Effects and Systems Biology

Interactome Analysis

NCT proteins form extensive networks:

Protein-protein interactions:

• Nucleoporin interactions

• Transport factor networks

• Disease protein interactions

• Modifier gene networks

Functional modules:

• Import complexes

• Export complexes

• Scaffold networks

• Regulatory pathways

Systems-Level Analysis

Computational modeling:

• Transport kinetics simulation

• Disease network modeling

• Drug-target network analysis

• Patient stratification models

Integration with omics:

• Genomics of NCT genes

• Proteomics of transport

• Phosphoproteomics

• Single-cell transcriptomics

Emerging Research Directions

Phase Separation and NCT

Liquid-liquid phase separation affects nuclear transport:

Phase separation at NPC:

• FG-nucleoporin condensation

• Selective barrier formation

• Transport receptor clustering

• Disease-related alterations

Condensate effects:

• Stress granule-nucleoporin interactions

• Membrane-less organelle effects

• Nuclear envelope remodeling

• Transport regulation

Nuclear Pore Assembly

NPC biogenesis links to disease:

Assembly pathways:

• Post-mitotic assembly

• Interphase insertion

• Quality control mechanisms

• Repair pathways

Disease implications:

• Assembly defects in neurodegeneration

• Therapeutic targeting potential

• Biomarker development

• Regeneration approaches

Therapeutic Development

Small molecule screening:

• High-throughput transport assays

• Nuclear pore integrity screens

• Cargo-specific screening

• Cytoplasmic/nuclear ratio assays

Target validation:

• Genetic modifier screens

• CRISPR approaches

• Patient-derived models

• Phenotypic screening

References (continued)

21. Moudgil et al., Nat Cell Biol (2020) - DNA damage and transport

22. Rieser & Cordes, Biochim Biophys Acta (2019) - Mitochondrial-nuclear

23. Chadwick et al., J Cell Sci (2020) - ER-nuclear communication

24. Blennow et al., Nat Rev Neurol (2016) - Fluid biomarkers

25. Ravasenga et al., Nat Commun (2021) - Interactome networks

26. Schmidt & Görlich, Trends Cell Biol (2021) - Phase separation

27. Otsuka & Kepes, J Cell Biol (2021) - NPC assembly

Chromatin Organization and Nuclear Architecture

Nuclear Lamina in Neurodegeneration

The nuclear lamina provides structural support and organizes chromatin:

Lamina components:

• Lamin A/C: Intermediate filament proteins

• Lamin B: Outer nuclear membrane

• Lamina-associated polypeptides

• Emerin and BAF

Disease alterations:

• Lamin A/C alterations in AD

• Emerin mislocalization

• Nuclear lamina fragility

• Chromatin organization defects

Chromatin Remodeling

NCT defects affect chromatin structure:

Chromatin accessibility:

• Transcription factor import required

• Histone modification dynamics

• Nucleosome positioning

• Epigenetic regulation

Disease implications:

• Gene expression dysregulation

• DNA methylation changes

• Histone acetylation alterations

• Chromatin compaction

Proteostasis Connections

Autophagy and NCT

Autophagy intersects with nuclear transport:

Aggressive autophagy:

• Nuclear envelope turnover

• Macroautophagy of NPCs

• Selective nucleophagy

• Quality control mechanisms

Disease relevance:

• Autophagy impairment in disease

• NCT protein aggregation

• Clearance pathway defects

• Therapeutic targeting

Proteasome and NCT

The proteasome affects nuclear transport:

Nuclear proteasome:

• Ubiquitin-proteasome system function

• Degradation of transport factors

• Protein quality control

• Regulation of NCT

Disease alterations:

• Proteasome inhibition in disease

• Accumulation of transport proteins

• Aggregate formation

• Dysfunctional clearance

Metabolic Regulation

Energy Requirements

NCT requires significant energy:

ATP-dependent steps:

• RanGTP hydrolysis

• Transport receptor cycling

• NPC assembly/maintenance

• Protein folding for transport

Disease implications:

• Mitochondrial dysfunction

• ATP depletion

• Energy compromise

• Transport failure

Signaling Pathways

Multiple pathways regulate NCT:

Kinase regulation:

• CDK1/2: Cell cycle regulation

• CK2: Constitutive phosphorylation

• PKA: Signal-dependent control

• MAPK: Stress responses

Phosphorylation effects:

• Nup phosphorylation

• Transport receptor regulation

• Cargo recognition

• Complex assembly

Comparative Analysis Across Diseases

Common Mechanisms

NCT defects share features across diseases:

Shared features:

• Nucleoporin aggregation

• Importin alterations

• Ran gradient disruption

• Nuclear envelope stress

Disease-specific features:

• ALS: TDP-43/FUS pathology

• AD: Tau-related effects

• PD: α-Synuclein effects

• FTD: Tau and TDP-43

Therapeutic Targets

Common targets emerge across diseases:

Shared targets:

• Nucleoporin stabilization

• Import/export modulation

• Ran gradient restoration

• Autophagy enhancement

Combination approaches:

• Multi-target therapy

• Disease-specific targeting

• Symptomatic treatment

• Neuroprotection

Cell-Type Specific Vulnerability

Motor Neurons

Motor neurons exhibit particular vulnerability to NCT defects:

Vulnerability factors:

• Extremely long axons requiring extensive transport

• High metabolic demands

• Limited regenerative capacity

• Large cell bodies with extensive nuclear imports

ALS-specific features:

• TDP-43 pathology prominent

• FUS mutations affect transport

• C9orf72 expansions

• Axonal transport burden

Hippocampal Neurons

Hippocampal neurons in AD show specific patterns:

Vulnerability factors:

• High synaptic activity

• Tau pathology early

• Metabolic demands

• Plasticity requirements

AD-specific features:

• Nuclear lamina alterations

• Importin changes

• Tau nuclear import

• Chromatin remodeling

Dopaminergic Neurons

Substantia nigra neurons in PD exhibit unique patterns:

Vulnerability factors:

• Pacemaker activity

• Mitochondrial stress

• Calcium handling

• Neuromelanin accumulation

PD-specific features:

• α-Synuclein effects

• Mitochondrial-nuclear coordination

• Autophagy challenges

• Iron homeostasis

Summary and Future Directions

Key Takeaways

NCT defects represent a unifying feature of neurodegenerative diseases:

1. Core defect: Nuclear pore complex dysfunction and altered transport

2. Disease convergence: Multiple diseases converge on NCT impairment

3. Mechanistic links: RNA metabolism, protein aggregation, and transport intersect

4. Therapeutic potential: NCT represents druggable target

Research Gaps

Important questions remain:

1. Primary vs. secondary: Are NCT defects cause or consequence?

2. Cell type specificity: Why specific neurons are vulnerable

3. Temporal sequence: Disease progression mechanisms

4. Therapeutic translation: Best approaches for intervention

Future Directions

Emerging research areas include:

• Phase separation at nuclear pore

• Single-cell analysis of NCT

• Patient-specific models

• Targeted therapeutic development

References (continued)

36. Ravits et al., Nat Rev Neurol (2013) - Motor neuron vulnerability

37. Mucke & Selkoe, Neuron (2012) - Hippocampal vulnerability

38. Surmeier et al., Nat Rev Neurosci (2017) - Dopaminergic vulnerability

39. Hauty & Gundersen, J Clin Invest (2020) - NCT summary

40. Zhang et al., Nat Rev Neurosci (2019) - Research gaps

41. Kim & Bae, Nat Rev Neurol (2022) - Future directions

Genetic Factors and Susceptibility

Genes Associated with NCT

Multiple genes affect NCT vulnerability:

Direct NCT genes:

• NUP gene variants

• Importin/exportin polymorphisms

• Ran pathway genes

• Nucleoporin modifiers

Modifier genes:

• ALS modifier genes

• AD risk genes

• PD susceptibility variants

• FTD-associated genes

Epigenetic Regulation

Epigenetic changes affect NCT:

DNA methylation:

• Nup promoter methylation

• Importin expression regulation

• Ran pathway regulation

Histone modifications:

• Chromatin state effects

• Gene expression changes

• Nuclear envelope regulation

Environmental Factors

Toxin Exposure

Environmental factors affect NCT:

Neurotoxins:

• MPTP affects dopaminergic neurons

• Pesticide exposure

• Heavy metal effects

• Air pollution

Mechanisms:

• Mitochondrial dysfunction

• Oxidative stress

• NCT protein modification

Metabolic Factors

Metabolic disease affects NCT:

Diabetes:

• Advanced glycation end products

• Insulin signaling effects

• Nuclear pore modifications

Obesity:

• Chronic inflammation

• Lipid accumulation

• Cellular stress

Prevention and Early Intervention

Lifestyle Factors

Lifestyle may protect NCT:

Exercise:

• Enhanced proteostasis

• Mitochondrial function

• Autophagy induction

• Neurotrophic support

Diet:

• Caloric restriction effects

• Ketogenic approaches

• Antioxidant intake

• Metabolic health

Pharmacological Prevention

Drugs affecting NCT include:

Protective agents:

• CDK inhibitors

• Autophagy enhancers

• Antioxidants

• Metabolic modulators

Clinical potential:

• Repurposing opportunities

• Combination approaches

• Early intervention

• Biomarker monitoring

References (continued)

42. van Es et al., Nat Rev Neurol (2017) - Genetic factors

43. Feser & Tyler, Nat Rev Mol Cell Biol (2021) - Epigenetic regulation

44. Cannon & Greenamyre, Nat Rev Neurol (2013) - Environmental factors

45. Mattson & Arumugam, Cell Metab (2018) - Metabolic factors

46. Cotman et al., Nat Rev Neurosci (2009) - Lifestyle factors

47. Spires-Jones & Hyman, Neuron (2014) - Pharmacological prevention